Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

AEye Reports Third Quarter 2023 Results

LIDR

Provides Update on Automotive-First Strategy

Significant Reduction in Burn Rate Extending Cash Runway out to 2025

AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high performance lidar solutions, today announced its results for the third quarter ended September 30, 2023.

Management Commentary

“Market conditions are evolving, and we believe the lidar market has shifted from a ‘battle for the best technology’ to a ‘battle for the best path to commercialization.’ We’ve been relentlessly focused on ensuring AEye enters the automotive market with a differentiated and superior product, so we are ready for the transition,” said Matt Fisch, AEye CEO. “We have recently taken decisive steps to optimize our operating and cost structure around our automotive-first strategy and are well positioned with the right technology, business model and resources to deliver sustained growth and success over the long-term.”

Key Q3 2023 Financial Highlights

“During the quarter, we achieved our goal of reducing our cash burn by 50% since the beginning of the year, one quarter sooner than anticipated. We have now aligned our expenses with our automotive-first strategy and have extended our cash runway into 2025. We closed the quarter with a healthy balance sheet, including $45.9 million of cash, and will continue to manage expenses carefully,” said Conor Tierney, AEye CFO. “The continued cost reduction initiatives in the third quarter were the main driver for meeting our GAAP EPS net loss guidance and beating our non-GAAP EPS net loss guidance by one cent.”

  • Revenue of $0.2 million in the third quarter of 2023.
  • GAAP net loss was $(17.0) million, or $(0.09) per share, based on 184.1 million weighted average common shares outstanding.
  • Non-GAAP net loss was $(9.5) million, or $(0.05) per share, based on 184.1 million weighted average common shares outstanding.
  • Cash, cash equivalents, and marketable securities were $45.9 million as of September 30, 2023.

Conference Call and Webcast Details

AEye management will hold a conference call today, November 9, 2023, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these results. AEye CEO Matt Fisch and CFO Conor Tierney will host the call, followed by a question-and-answer session.

The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.

Access is also available via:

Conference call: https://bit.ly/AEyeconferencecall

Webcast: https://bit.ly/AEyewebcast

About AEye

AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has a global presence through its offices in Germany, Korea, and the United States.

Non-GAAP Financial Measures

The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in the United States. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. AEye considers these non-GAAP financial measures to be important because they provide additional insight into the Company’s on-going performance. The Company provides this information to investors for a more consistent basis of comparison and to help investors evaluate the results of the Company’s on-going operations, and to help enable more meaningful period-to-period comparisons. Non-GAAP financial measures are presented only as supplemental information for the purpose of understanding the Company’s operating results. The non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP.

This press release includes non-GAAP financial measures, including:

  • Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus expenses related to the registration statements on Forms S-1s and S-3s, plus expenses related to the Common Stock Purchase Agreement, less change in fair value of convertible note and warrant liabilities, plus realized loss on instrument-specific credit risk, plus one-time termination benefits and restructuring costs, plus non-routine write-down of inventory, plus impairment of ROU assets, plus stock issuance costs, plus debt issuance costs; and
  • Adjusted EBITDA which is defined as non-GAAP net loss plus depreciation and amortization expense, plus interest expense and other, less interest income and other, plus provision for income tax expense.

Forward-Looking Statements

Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about the adaptability, benefits, and features of AEye’s products, the competitive advantages of AEye’s business model, as well as the use of lidar in automobiles generally, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of AEye. Many factors could cause actual future events to differ from the forward-looking statements in this press release, including but not limited to: (i) the risks that AEye’s 4Sight Intelligent Sensing Platform’s software-definable lidar may not enhance advanced driver assistance systems (ADAS) capabilities, enable next gen safety features, nor enable software revenue opportunities as anticipated, or at all; (ii) the risks that the 4Sight reference designs may not be differentiated technically by their range, resolution, reliability, and reconfigurability to the extent anticipated, or at all; (iii) the risk that the licenses to Tier 1 automotive suppliers may not result in high volume manufacturing in the time frame anticipated, or at all; (iv) the risks that the automotive industry may not rely on software architectures as anticipated, or at all; (v) the risks that AEye’s 4Sight Intelligent Sensing Platform may not reduce time-to-market for new features, allow OEMs to continuously improve upon or introduce features and functionality across all vehicle models through software upgrades, or allow OEMs to deliver a future-proofed ADAS roadmap as anticipated, or at all; (vi) the risks that lidar adoption occurs slower than anticipated or fails to occur at all; (vii) the risks that AEye’s products may not meet the diverse range of performance and functional requirements of target markets and customers; (viii) the risks that AEye’s products may not function as anticipated by AEye, or by target markets and customers; (ix) the risks that AEye may not be in a position to adequately or timely address either the near or long-term opportunities that may or may not exist in the evolving autonomous transportation industry; (x) the risks that laws and regulations are adopted impacting the use of lidar that AEye is unable to comply with, in whole or in part; (xi) the risks associated with changes in competitive and regulated industries in which AEye operates, variations in operating performance across competitors, and changes in laws and regulations affecting AEye’s business; (xii) the risks that AEye is unable to adequately implement its business plans, forecasts, and other expectations, and identify and realize additional opportunities; and (xiii) the risks of downturns and a changing regulatory landscape in the highly competitive and evolving industry in which AEye operates. These risks and uncertainties may be amplified by the lingering effects of the COVID-19 pandemic, which continues to cause significant economic uncertainty. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the periodic report that AEye has most recently filed with the U.S. Securities and Exchange Commission, or the SEC, and other documents filed by us or that will be filed by us from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made.

Readers are cautioned not to put undue reliance on forward-looking statements; AEye assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. AEye gives no assurance that AEye will achieve any of its expectations.

AEYE, INC.
Consolidated Balance Sheets
(In thousands)
(Unaudited)
September 30, 2023 December 31, 2022
ASSETS
Current Assets:
Cash and cash equivalents $

37,149

$

19,064

Marketable securities

8,743

75,135

Accounts receivable, net

238

617

Inventories, net

4,868

4,553

Prepaid and other current assets

4,509

6,181

Total current assets

55,507

105,550

Right-of-use assets

14,397

15,502

Property and equipment, net

7,787

7,665

Restricted cash

2,150

2,150

Other noncurrent assets

1,040

2,473

Total assets $

80,881

$

133,340

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable $

4,707

$

3,218

Accrued expenses and other current liabilities

7,247

9,764

Contract liabilities

18

987

Convertible notes

8,594

Total current liabilities

11,972

22,563

Operating lease liabilities, noncurrent

15,484

16,681

Other noncurrent liabilities

82

126

Total liabilities

27,538

39,370

Stockholders' Equity:
Preferred stock

Common stock

19

16

Additional paid-in capital

363,176

345,742

Accumulated other comprehensive income (loss)

1

(1,279

)

Accumulated deficit

(309,853

)

(250,509

)

Total stockholders’ equity

53,343

93,970

Total liabilities and stockholders’ equity $

80,881

$

133,340

AEYE, INC.
Consolidated Statements of Operations
(In thousands, except share and per share data)
(Unaudited)
Three months ended September 30, Nine months ended September 30,

2023

2022

2023

2022

Revenue:
Prototype sales $

56

$

652

$

426

$

1,182

Development contracts

132

115

969

1,373

Total revenue

188

767

1,395

2,555

Cost of revenue

4,479

2,708

8,651

5,617

Gross loss

(4,291

)

(1,941

)

(7,256

)

(3,062

)

Operating Expenses:
Research and development

5,654

8,971

20,993

28,309

Sales and marketing

1,910

4,466

10,782

14,405

General and administrative

5,380

7,896

20,279

29,053

Total operating expenses

12,944

21,333

52,054

71,767

Loss from operations

(17,235

)

(23,274

)

(59,310

)

(74,829

)

Other income (expense):
Change in fair value of convertible note and warrant liabilities

12

16

(914

)

125

Interest income and other

354

335

932

1,109

Interest expense and other

(174

)

(688

)

(9

)

(1,338

)

Total other income (expense), net

192

(337

)

9

(104

)

Provision for income tax expense

5

13

43

39

Net loss $

(17,048

)

$

(23,624

)

$

(59,344

)

$

(74,972

)

Per Share Data
Net loss per common share (basic and diluted) $

(0.09

)

$

(0.15

)

$

(0.34

)

$

(0.48

)

Weighted average common shares outstanding (basic and diluted)

184,117,531

159,312,203

172,182,776

156,702,000

AEYE, INC.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine months ended September 30,

2023

2022

Cash flows from operating activities:
Net loss $

(59,344

)

$

(74,972

)

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

998

794

Loss on sale of property and equipment, net

53

Noncash lease expense relating to operating lease right-of-use assets

1,058

993

Impairment of right-of-use assets

47

Inventory write-downs, net of scrapped inventory

3,666

576

Change in fair value of convertible note and warrant liabilities

914

(125

)

Realized loss on instrument-specific credit risk

46

Stock-based compensation

14,707

18,003

Realized loss on redemption of marketable securities

77

Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest

33

1,211

Changes in operating assets and liabilities:
Accounts receivable, net

379

3,598

Inventories, current and noncurrent, net

(2,681

)

(2,256

)

Prepaid and other current assets

1,672

(445

)

Other noncurrent assets

133

420

Accounts payable

1,494

(1,236

)

Accrued expenses and other current liabilities

(2,571

)

220

Operating lease liabilities

(1,143

)

(983

)

Contract liabilities

(969

)

(1,400

)

Net cash used in operating activities

(41,508

)

(55,525

)

Cash flows from investing activities:
Purchase of property and equipment

(1,421

)

(3,402

)

Proceeds from sale of property and equipment

243

Purchase of marketable securities

(8,736

)

Proceeds from redemptions and maturities of marketable securities

76,350

93,592

Net cash provided by investing activities

66,436

90,190

Cash flows from financing activities:
Proceeds from exercise of stock options

450

1,032

Proceeds from the issuance of convertible notes

10,000

Payments for convertible note redemptions

(6,235

)

Taxes paid related to the net share settlement of equity awards

(1,312

)

(4,252

)

Proceeds from issuance of common stock under the Common Stock Purchase Agreement

136

2,891

Proceeds from issuance of common stock through Employee Stock Purchase Plan

118

Stock issuance costs related to the Common Stock Purchase Agreement

(29

)

Net cash (used in) provided by financing activities

(6,843

)

9,642

Net increase in cash, cash equivalents and restricted cash

18,085

44,307

Cash, cash equivalents and restricted cash at beginning of period

21,214

16,333

Cash, cash equivalents and restricted cash at end of period $

39,299

$

60,640

AEYE, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except share and per share data)
(Unaudited)

Three months ended September 30,

Nine months ended September 30,

2023

2022

2023

2022

GAAP net loss $

(17,048

)

$

(23,624

)

$

(59,344

)

$

(74,972

)

Non-GAAP adjustments:
Stock-based compensation

4,084

6,106

14,707

18,003

Expenses related to registration statement on Form S-1s and Form S-3s

192

54

192

304

Expenses related to the Common Stock Purchase Agreement

41

41

Change in fair value of convertible note and warrant liabilities

(12

)

(16

)

914

(125

)

Realized loss on instrument-specific credit risk

46

46

Stock issuance costs

28

Debt issuance costs

437

437

One-time termination benefits and restructuring costs

172

1,470

Non-routine write-down of inventory

3,007

3,007

Impairment of right-of-use assets

47

Non-GAAP net loss $

(9,518

)

$

(17,043

)

$

(38,920

)

$

(56,325

)

Depreciation and amortization expense

332

331

998

794

Interest income and other

(354

)

(335

)

(932

)

(1,109

)

Interest expense and other

128

307

(84

)

928

Provision for income tax expense

5

13

43

39

Adjusted EBITDA $

(9,407

)

$

(16,727

)

$

(38,895

)

$

(55,673

)

GAAP net loss per share attributable to common stockholders:
Basic and diluted $

(0.09

)

$

(0.15

)

$

(0.34

)

$

(0.48

)

Non-GAAP net loss per share attributable to common stockholders:
Basic and diluted $

(0.05

)

$

(0.11

)

$

(0.23

)

$

(0.36

)

Shares used in computing GAAP net loss per share attributable to common stockholders:
Basic and diluted

184,117,531

159,312,203

172,182,776

156,702,000

Shares used in computing Non-GAAP net loss per share attributable to common stockholders:
Basic and diluted

184,117,531

159,312,203

172,182,776

156,702,000